MORRIS PLAINS, N.J., April 10, 2014 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that Dr. David M. Goldenberg, Founder and Chairman of the Board, and Cynthia L. Sullivan, President and Chief Executive Officer, will ring the Opening Bell at the NASDAQ MarketSite in Times Square, New York City, on Wednesday, April 23, 2014, in honor of the Company’s 30-year uninterrupted listing on the NASDAQ Stock Market. Following the Opening Bell Ceremony, the Company will host a R&D day at the NASDAQ MarketSite.
Help employers find you! Check out all the jobs and post your resume.